ReviewEndocrinology and metabolism clinics of North America2019
Dermatologic Conditions in Transgender Populations.
Review in Endocrinology and metabolism clinics of North America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Injectable Aesthetic Treatments for Improving Facial Skin Quality in Transgender Patients With or Without Gender-Affirming Hormone Therapy.Journal of cosmetic dermatology · 2025Article
- Investigating Experiences With Scarring Among Transgender and Gender Diverse People: Mixed Methods Study.JMIR dermatology · 2025Article
- Insights Into Skin-Lightening Practices of Hijra and Transgender Communities in India.JMIR dermatology · 2025Article
- Long-Term Follow-Up of Gender-Affirming Chest Masculinization: What Have We Learned About Patient Satisfaction and Psychological Well-Being?Journal of clinical medicine · 2025Article
- Accuracy of Anthropometric Equations in Estimating Body Fat Percentage in Transgender Men Undergoing Gender-Affirming Hormone Therapy.International journal of exercise science · 2025Article
- Biopsychosocial impact of keloids on quality of life.JAAD reviews · 2024Article
- Association of polycystic ovary syndrome with atopic dermatitis: a case control study.Archives of dermatological research · 2024Article
- Prevalence of Psoriasis and Perceived Association with Hormone Therapy in Transgender Adults.Transgender health · 2023Article
- Distinguishing Gender Identity From Biological Sex in Dermatologic Health Care: Methods, Harms, and Paths Forward.JMIR dermatology · 2023Article
- Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults.The journal of sexual medicine · 2023Article
- Caring for transgender populations: A primer for the dermatopathologist.Journal of cutaneous pathology · 2023Article
- Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study.Transgender health · 2023Article
- Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide.American journal of clinical dermatology · 2022Article
- Sex, Genes, and Traumatic Brain Injury (TBI): A Call for a Gender Inclusive Approach to the Study of TBI in the Lab.Frontiers in neuroscience · 2021Article
- Effects of testosterone treatment on transgender males: A single-institution study.SAGE open medicine · 2021Article
- Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy.JAAD case reports · 2020Article
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications.Journal of cutaneous medicine and surgeryReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Transgender persons receiving gender-affirming hormone therapy and procedures may face specific skin conditions. Skin diseases in transgender patients often are underdiagnosed and underrecognized despite their important impact on quality of life and mental health. This article discusses pathophysiology, diagnosis, and treatment of common skin diseases in the transgender populations. For transmasculine patients, conditions include acne vulgaris and male pattern hair loss. For transfeminine patients, conditions include hirsutism, pseudofolliculitis barbae, and melasma. Postprocedural keloids and other cutaneous complications are discussed. Unique aspects of skin health in transgender persons should be considered in the context of multidisciplinary gender-affirming care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.